Biotech China 2014

View Profile


Grant Support

Start year End year Title Source Position
1. 2008 2010 Crohn’s and Colitis Foundation Pregnancy Registry Crohn’s and Colitis Foundation of America Site PI
2. 2008 2010 The Effect of Personal Beliefs, Self-efficacy, Medications, and Chronic Illness on Adherence to Surveillance Colonoscopy in IBD Proctor and Gamble, Inc PI
3. 2008 2009 Humira Registry Abbott Inc Site PI
4. 2007 2009 A Colonoscopy Appointment Reminder System: Effect on Adherence to Colonoscopy in Patients with IBD Proctor and Gamble, Inc PI
5. 2006 2009 Adherence to Screening and Surveillance Colonoscopy in Inflammatory Bowel Disease: A Pilot Study Proctor and Gamble, Inc PI
6. 2004 2006 The 5-ASA – 6-MP/AZA Interaction and its Effect on Clinical Efficacy Proctor and Gamble, Inc PI
7. 2004 2005 Crohn’s and Colitis Foundation of America Research Initiative Award in Support of the DNA and Cell Line Bank/Sample Collections BWH Site PI
8. 2002 2005 A Phase III, Multi-center, Placebo-Controlled Trial of Infliximab in Inducing and Maintaining Remission in Ulcerative Colitis Centocor, Inc PI
9. 2002 2005 The Efficacy of Ciprofloxacin Versus Flagyl in Perianal Fistulizing Crohn’s disease CCFA Clinical Research Alliance Study Co PI
10. 2002 2004 A Phase III, Multi-center, Randomized, Placebo-Controlled Trial of Tegaserod in Women with Constipation-Predominant Irritable Bowel Syndrome Novartis Pharmaceuticals Site PI
11. 2002 2004 A Phase III, Multi-center, Placebo-Controlled Trial of Adalimumab, a Humanized Anti TNF Monoclonal antibody, in Inducing and Maintaining Remission in Crohn’s Disease Abbott Pharmaceuticals Co PI
12. 2001 2003 NOCIS Study. (New onset Crohn’s intervention study). Multi-center trial to evaluate the efficacy of 6-mercaptopurine in new onset Crohn’s disease NOCIS Co PI
13. 1998 1999 A Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of High Dose Asacol for the Treatment of Crohn’s Ileitis, Ileocolitis, and Colitis Proctor and Gamble PI
14. 1998 1998 An Open-Label Trial of the Use of Subcutaneous Octreotide for the Treatment of Mild to Moderate Ulcerative Colitis Novartis Pharmaceuticals PI
15. 1987 1989 Role of action potential activity in nerve cell death during central nervous system development. National Science Foundation Grant for Undergraduate Research PI
16. 1987 1989 Role of optic nerve glial cells in visual system development Firestone Research Grant, Stanford University PI


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.